Capsaicin-, Resmiferatoxin-, and Lactic Acid-Evoked Vascular Effects in the Pig Nasal Mucosa in vivo with Reference to Characterization of the Vanilloid Receptor

Pharmacology and Toxicology

Volumn 78, Issue 5, 1996, Pages 327-335

  Rinder, Johan ^a,b   Szallasi, Arpad ^a   Lundberg, Jan M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SUS SCROFA; ANIMALIA;

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CAPSAICIN; CAPSAZEPINE; CHLORISONDAMINE; DICLOFENAC; LACTIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTON; RADIOLIGAND; RECEPTOR SUBTYPE; RESINIFERATOXIN; VANILLOID RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD FLOW; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; FEMALE; HEART RATE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE BINDING; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; PRIORITY JOURNAL; REFLEX; SKIN BLOOD FLOW; SPLEEN; SWINE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CAPSAICIN; DITERPENES; FEMALE; LACTIC ACID; MALE; NASAL MUCOSA; NEUROTOXINS; RECEPTORS, DRUG; SWINE;

EID: 0029927249     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb01384.x     Document Type: Article

References (36)

1. 3H]resiniferatoxin binding by the vanilloid receptor in dorsal root ganglia, spinal cord, dorsal vagal complex, sciatic and vagal nerve and urinary bladder of the rat. Life Sci. 1994, 55, 1017-1026.
2. Auberson, S. & J. M. Lundberg: Lactic acid-induced plasma protein extravasation by stimulation of sensory nerves and NK1 receptor activation. Pharmacology & Toxicology 1993, 73, 305-310.
3. Belvisi, M. G., M. Miura, D. Stretton & P. J. Barnes: Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchi. Eur. J. Pharmacol. 1992, 215, 341-344.
4. Bevan, S., S. Hothi, G. Hughes, I. F. James, H. P. Rang, K. Shah, C. S. J. Walpole & J. C. Yeats: Development of a competitive antagonist for the sensory neuron excitant, capsaicin. Brit. J. Pharmacol. 1992, 104, 77P.
5. Delay-Goyet, P., H. Satoh & J. M. Lundberg: Relative involvement of substance P and CGRP mechanisms in antidromic vasodilatation in the rat skin. Acta physiol. scand. 1992, 146, 537-538.
6. Ellis, J. L. & B. J. Undem: Inhibition by capsazepine of resiniferatoxin- and capsaicin-induced contractions of guinea-pig trachea. J. Pharmacol. Exp. Therap. 1994, 268, 85-89.
7. Franco-Cereceda, A., G. Källner & J. M. Lundberg: Cyclo-oxygenase products released by low pH have capsaicin-like actions on sensory nerves in the isolated guinea-pig heart. Cardiovasc. Res. 1994, 28, 365-369.
8. Hilberg, O., A. C. Jackson, D. L. Swift & O. F. Pedersen: Acoustic rhinometry: evaluation of nasal geometry by acoustic reflection. J. Appl. Physiol. 1989, 66(1), 295-303.
9. Hughes, S. R. & S. D. Brain: A calcitonin gene-related peptide (CGRP) antagonist (CGRP 8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Brit. J. Pharmacol. 1991, 104, 738-742.
10. Jackson, A. C., J. P. Butler, E. J. Millet, F. G. Hoppin jr & S. V. Dawson: Airway geometry by analysis of acoustic pulse response measurements. J. Appl. Physiol. 1977, 43, 523-536.
11. Kerezoudis, N. P., L. Olgart & L. Edwall: CGRP (8-37) reduces the duration but not the maximal increase of antidromic vasodilatation in dental pulp and lip of the rat. Acta physiol., scand. 1994, 151, 73-81.
12. Lacroix, J. S., P. Stjärne, A. Änggård & J. M. Lundberg: Sympathetic vascular control of the pig nasal mucosa (2): reserpineresistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta physiol. scand. 1988, 133, 183-197.
13. Longhurst, J. C., D. M. Rotto, M. P. Kaufman & G. L. Stahl: Ischemically sensitive abdominal visceral afferents: response to cyclooxygenase blockade. Amer. J. Physiol. 1991, 261, 2075-2081.
14. Lou, Y.-P. & J. M. Lundberg: Inhibition of low pH evoked activation of airway sensory nerves by capsazepine, a novel capsaic-in-receptor antagonist. Biochem. Biophys. Res. Comm. 1992, 189, 537-544.
15. Lundblad, L., A. Saria, J. M. Lundberg & A. Änggård: Increased vascular permeability in the rat nasal mucosa induced by substance P and stimulation of capsaicin sensitive trigeminal neurons. Acta otolaryngol. (Stockh.) 1983, 96, 479-484.
16. Maggi, C. A., R. Patacchini, M. Tramontana, R. Amann, S. Giuliani & P. Santicioli: Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons. Neuroscience 1990, 37, 531-539.
17. Maggi, C. A., S. Bevan, C. S. J. Walpole, H. P. Rang & S. Giuliani: A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferences. Brit. J. Pharmacol. 1993, 108, 801-805.
18. Martling, C.-R. & J. M. Lundberg: Capsaicin sensitive afferents contribute to the acute airways oedema following tracheal instillation of hydrochloride acid or gastric juice in the rat. Anaesthesiology 1988, 68, 350-356.
19. Petersson, G., L. Malm, R. Ekman & R. Håkanson: Capsaicin evokes secretion of nasal fluid and depletes substance P and calcitonin gene-related peptide from the nasal mucosa in the rat. Brit. J. Pharmacol. 1989, 98, 930-936.
20. 1-receptor antagonist SR 140.333 on capsaicin-evoked vasodilatation in the pig nasal mucosa in vivo. Acta physiol. scand. 1996, in press.
21. Rinder, J., P. Stjärne & J. M. Lundberg: Capsaicin desensitisation of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology 1994, 32, 173-178.
22. + activity in cat hindlimb muscle. J. Appl. Physiol. 1989, 67, 256-263.
23. Santicioli, P., E. Del Bianco, M. Figini, S. Bevan & C. A. Maggi: Effect of capsazepine on the release of calcitonin gene-related peptide-like immunoreactivity (CGRP-LI) induced by low pH. capsaicin and potassium in rat soleus muscle. Brit. J. Pharmacol. 1993, 110, 609-612.
24. + derived from lactic acid and hypercapnia. Amer. J. Physiol. 1992 262 (Heart Circ. Physiol. 31), H748-H753.
25. Stjärne, P., J. S. Lacroix, A. Änggård & J. M. Lundberg: Release of calcitonin gene-related peptide in the pig nasal mucosa by antidromic nerve stimulation and capsaicin. Regul. Pept. 1991, 33, 251-262.
26. Stjärne, P., L. Lundblad & J. M. Lundberg: Mechanical stimulation and capsaicin evoked vasodilatation by parasympathetic reflex mechanisms. Acta otolaryngol. (Stockh.) 1993, 113, 649-654.
27. 3H]resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord. Eur. J. Pharmacol. Mol. Pharmacol. 1995, 289, 181-187.
28. Szallasi, A. & P. M. Blumberg: Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci. 1990, 47, 1399-1408.
29. Szallasi, A. & P. M. Blumberg: Resiniferatoxin. In: Methods in neurosciences 8. Ed.: P. M. Conn. Academic Press, Orlando, FL, 1992, pp. 368-380.
30. Szallasi, A., N. E. Lewin & P. M. Blumberg: Identification of alphal-acid glycoprotein (orosomucoid) as a major vanilloid-binding protein in serum. J. Pharmacol. Exp. Therap. 1992, 262, 883-888.
31. Szallasi, A., B. Conte, C. Goso, P. M. Blumberg & S. Manzini: Characterization of a peripheral vanilloid (capsaicin) receptor in the rat urinary bladder. Life Sci. 1993a, 52, PL 221-226.
32. 3H]resiniferatoxin binding to central (dorsal root ganglia, spinal cord) and peripheral (urinary bladder, airways) vanilloid (capsaicin) receptors in the rat. J. Pharmacol. Exp. Therap. 1993b, 267, 728-733.
33. 3H]resiniferatoxin binding of vanilloid (capsaicin) receptors in guinea-pig airways: regional differences, and affinity for capsazepine. Neuropeptides 1993c, 24, C4.
34. Szallasi, A.: The vanilloid (capsaicin) receptor: receptor types and species differences. Gen. Pharmacol. 1994, 25, 223-243.
35. +. Proc. Natl. Acati. Sci. (USA) 1990, 87, 6445-6449.
36. Winter, J., A. Dray, J. N. Wood, J. C. Yeats & S. Bevan: Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res. 1990, 520, 131-140.